64 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
, provide to Purchaser the benefits and Purchaser shall assume the obligations and bear the economic burdens associated with such Non-Transferred Asset … such provisions and to avail themselves of the benefits of any remedy for any breach of such provisions, all to the same extent as if such Persons were parties
8-K
EX-99.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
product.”
Impel intends to continue operating as usual throughout the court-supervised sale process, including providing wages and benefits
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
14 Nov 23
Departure of Directors or Certain Officers
4:01pm
by the Administrator, except as may be explicitly provided otherwise herein. Plan terms shall govern all benefits payable under the Plan.
3. Eligibility … and all benefit determinations, including, but not limited to, amounts of benefits, eligibility, and the occurrence of a Corporate Transaction shall
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
with the delivery of, or payment for, health care benefits, items or services relating to health care matters;
HIPAA, as amended by the Health … to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial statements may therefore
8-K
EX-10.1
z5chc7 u1f23u4dmpb
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-99.1
wfqj9b4e9obwd7
18 Sep 23
Regulation FD Disclosure
9:53pm
8-K
EX-10.3
28mzfxk8
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.4
6gqg k5oaw
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
wugt2it
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
1qhr074050dy9yu10p85
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
8-K
EX-99.1
rkd m6m6y9jwm95uask
12 May 23
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
8:03am
8-K
c9k8dal9brxra3es8
10 May 23
Departure of Directors or Certain Officers
8:10am
PRE 14A
0op6b3h5bk0eyvs
14 Apr 23
Preliminary proxy
4:11pm
8-K
EX-99.1
ebsyk39m3ure8nuyn40l
14 Nov 22
Impel PHARMACEUTICALS Announces THIRD Quarter 2022 Financial Results and Provides CORPORATE Update
7:55am